Page last updated: 2024-08-24

isoborneol and edaravone

isoborneol has been researched along with edaravone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Gao, C; Li, X; Li, Y; Wang, L; Xue, M1
Gao, LY; Hua, Y; Liao, GY; Luo, CX; Sun, WX; Tang, Y; Wu, HY; Yang, SB; Zhang, ZP; Zhou, QG; Zhu, DY1
Feng, L; Liu, L; Shen, Y; Sun, Y; Wu, X; Xu, F; Xu, Q; Zhang, X1
Chen, H; Chen, X; Dong, A; Gao, Z; Geng, D; Ji, Y; Li, S; Liu, B; Lu, Z; Meng, X; Mu, H; Wang, A; Wang, Y; Xu, A; Xu, J; Yalkun, G; Zhao, X; Zheng, H; Zhu, R1
An, W; Chen, R; Hua, Y; Kou, X; Ren, J; Su, H; Yang, W; Zhang, Z; Zhao, Z; Zhou, L; Zou, J1
Gao, Y; Li, H; Li, Z; Liang, C; Liu, Z; Peng, P; Qi, D; Yang, Z; Zhang, Q1

Trials

1 trial(s) available for isoborneol and edaravone

ArticleYear
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
    Stroke, 2021, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antioxidants; Camphanes; Double-Blind Method; Edaravone; Female; Humans; Ischemic Stroke; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome

2021

Other Studies

5 other study(ies) available for isoborneol and edaravone

ArticleYear
Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:3

    Topics: Animals; Antioxidants; Antipyrine; Brain; Camphanes; Chromatography, High Pressure Liquid; Drug Interactions; Drugs, Chinese Herbal; Edaravone; Free Radical Scavengers; Half-Life; Isoflavones; Limit of Detection; Male; Metabolic Clearance Rate; Microdialysis; Random Allocation; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2010
The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
    European journal of pharmacology, 2014, Oct-05, Volume: 740

    Topics: Animals; Anti-Inflammatory Agents; Antipyrine; Brain; Brain Ischemia; Camphanes; Cell Survival; Cells, Cultured; Coculture Techniques; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Edaravone; Free Radical Scavengers; Interleukin-1beta; Maze Learning; Neuroglia; Neurons; Rats, Sprague-Dawley; Stroke; Tumor Necrosis Factor-alpha

2014
(+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway.
    International immunopharmacology, 2017, Volume: 53

    Topics: Animals; Antipyrine; Camphanes; Cell Differentiation; Cells, Cultured; Colitis; Colon; Cytokines; Dextran Sulfate; Drug Combinations; Edaravone; Female; Inflammation; Janus Kinase 2; Macrophages; Mice; Mice, Inbred C57BL; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Th2 Cells

2017
Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats.
    European journal of pharmacology, 2021, Nov-05, Volume: 910

    Topics: Animals; Brain Edema; Camphanes; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Drug Combinations; Edaravone; Humans; Male; Neuroprotective Agents; Rats

2021
Herb-drug interaction of Xingnaojing injection and Edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 112

    Topics: Animals; Chromatography, Liquid; Edaravone; Glucuronosyltransferase; Herb-Drug Interactions; Ischemic Stroke; Molecular Docking Simulation; Rats; Tandem Mass Spectrometry

2023